Yizhou Dong

14.4k total citations · 6 hit papers
110 papers, 9.3k citations indexed

About

Yizhou Dong is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Yizhou Dong has authored 110 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 14 papers in Immunology and 13 papers in Oncology. Recurrent topics in Yizhou Dong's work include RNA Interference and Gene Delivery (53 papers), Advanced biosensing and bioanalysis techniques (33 papers) and CRISPR and Genetic Engineering (14 papers). Yizhou Dong is often cited by papers focused on RNA Interference and Gene Delivery (53 papers), Advanced biosensing and bioanalysis techniques (33 papers) and CRISPR and Genetic Engineering (14 papers). Yizhou Dong collaborates with scholars based in United States, China and Taiwan. Yizhou Dong's co-authors include Xucheng Hou, Róbert Langer, Tal Zaks, Daniel G. Anderson, Bin Li, Yuebao Zhang, Xinfu Zhang, Chang Wang, Weiyu Zhao and Daniel J. Siegwart and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Yizhou Dong

102 papers receiving 9.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipid nanoparticles for mRNA delivery

2021 2.4k citations Xucheng Hou, Róbert Langer et al. profile →
Lipids and Lipid Derivatives for RNA Delivery

2021 461 citations Yuebao Zhang, Chang Wang et al. profile →
Strategies, design, and chemistry in siRNA delivery systems

2019 456 citations Yizhou Dong, Daniel J. Siegwart et al. Advanced Drug Delivery Reviews profile →
Intratumoral delivery of IL-12 and IL-27 mRNA using lipid nanoparticles for cancer immunotherapy

2022 178 citations Jin-Qing Liu, Chengxiang Zhang et al. profile →
Lipid Nanoparticle–mRNA Formulations for Therapeutic Applications

2021 173 citations Chang Wang, Yuebao Zhang et al. profile →
LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing

2024 46 citations Yonger Xue, Yuebao Zhang et al. Nature Communications profile →

Peers

Countries citing papers authored by Yizhou Dong

Since Specialization

Citations

This map shows the geographic impact of Yizhou Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yizhou Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yizhou Dong more than expected).

Fields of papers citing papers by Yizhou Dong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yizhou Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yizhou Dong. The network helps show where Yizhou Dong may publish in the future.

Co-authorship network of co-authors of Yizhou Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yizhou Dong. A scholar is included among the top collaborators of Yizhou Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yizhou Dong. Yizhou Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Silver Induced In-Phase Electronic Interaction and Chloride Ion Repelling for Efficient Electrocatalytic Oxygen Evolution in Seawater Electrolysis	ACS Applied Energy Materials	Ruiqi Cheng, Min Jiang et al.	1
2	Aminophosphonate-Derived lipid nanoparticles enable circular RNA delivery for functional recovery after spinal cord injury	Materials Today	Yuebao Zhang, Kaiyuan Guo et al.	0
3	Chemical strategies for brain delivery of genomic therapy	Nature Reviews Chemistry	Tamara Markovic, Eric J. Nestler et al.	0
4	SCORT–Cas13d Nanotherapy Precisely Targets the ‘Undruggable’ Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo	Advanced Science	Zhifen Cui, Furong Huang et al.	2
5	Intravenous administration of blood–brain barrier-crossing conjugates facilitate biomacromolecule transport into central nervous system	Nature Biotechnology	Chang Wang, Siyu Wang et al.	16
6	Engineering LNPs with polysarcosine lipids for mRNA delivery	Bioactive Materials	Diana D. Kang, Xucheng Hou et al.	36
7	LNP-RNA-engineered adipose stem cells for accelerated diabetic wound healing breakdown →	Nature Communications	Yonger Xue, Yuebao Zhang et al.	46
8	Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics	Advanced Drug Delivery Reviews	Diana D. Kang, Haoyuan Li et al.	58
9	Cholesterol‐Amino‐Phosphate (CAP) Derived Lipid Nanoparticles for Delivery of Self‐Amplifying RNA and Restoration of Spermatogenesis in Infertile Mice	Advanced Science	Shi Du, Wenqing Li et al.	36
10	Nanotechnology-based mRNA vaccines	Nature Reviews Methods Primers	Shuying Chen, Xiangang Huang et al.	98
11	Lysosomal cystine governs ferroptosis sensitivity in cancer via cysteine stress response	Molecular Cell	Robert V. Swanda, Quanquan Ji et al.	38
12	Close the cancer–immunity cycle by integrating lipid nanoparticle–mRNA formulations and dendritic cell therapy	Nature Nanotechnology	Yuebao Zhang, Xucheng Hou et al.	66
13	IL-27 Induces CCL5 Production by T Lymphocytes, Which Contributes to Antitumor Activity	The Journal of Immunology	Aiyan Hu, Jianmin Zhu et al.	10
14	Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection	Nature Chemical Biology	Zhifen Cui, Cong Zeng et al.	39
15	Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing	Science Advances	Xinfu Zhang, Weiyu Zhao et al.	151
16	Chemotherapy drugs derived nanoparticles encapsulating mRNA encoding tumor suppressor proteins to treat triple-negative breast cancer	Nano Research	Chengxiang Zhang, Xinfu Zhang et al.	50
17	Lipid Polymer Hybrid Nanomaterials for mRNA Delivery	Cellular and Molecular Bioengineering	Weiyu Zhao, Chengxiang Zhang et al.	64
18	Dendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature	DSpace@MIT (Massachusetts Institute of Technology)	Carmen M. Barnés, Omar F. Khan et al.	5
19	Nucleic acid-mediated intracellular protein delivery by lipid-like nanoparticles	Biomaterials	Ahmed A. Eltoukhy, Delai Chen et al.	38
20	Antitumor agents 287. Substituted 4-amino-2H-pyran-2-one (APO) analogs reveal a new scaffold from neo-tanshinlactone with in vitro anticancer activity	Bioorganic & Medicinal Chemistry Letters	Yizhou Dong, Kyoko Nakagawa‐Goto et al.	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact